An Overview of New Drugs Approved in the US and EU in July 2019

In July 2019, US Food and Drug Administration (FDA) and European Commission had totally approved 14 new drugs, including new molecular entities, new active ingredient, new biologics and new line extensions (new indications and new formulations). In this article, new molecular entities, new active ingredients and new biologics receiving their first global approval were analyzed with emphasis on the outcomes of clinical trials and development histories.